114 related articles for article (PubMed ID: 16986710)
1. [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia].
Ohnishi K
Rinsho Ketsueki; 2006 Aug; 47(8):717-23. PubMed ID: 16986710
[No Abstract] [Full Text] [Related]
2. Sustained molecular remission after arsenic trioxide and gemutuzumab ozogamicin in a pediatric patient with relapsed acute promyelocytic leukemia.
Inoue A; Kawakami C; Takitani K; Tamai H
Pediatr Hematol Oncol; 2012 Mar; 29(2):170-2. PubMed ID: 22292427
[No Abstract] [Full Text] [Related]
3. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
[TBL] [Abstract][Full Text] [Related]
4. [Antileukemic].
Inomata T; Sunami K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():191-4. PubMed ID: 25831750
[No Abstract] [Full Text] [Related]
5. Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
Naina HV; Levitt D; Vusirikala M; Anderson LD; Scaglioni PP; Kirk A; Collins RH
J Clin Oncol; 2011 Jun; 29(18):e534-6. PubMed ID: 21482998
[No Abstract] [Full Text] [Related]
6. Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.
Grigg A; Kimber R; Szer J
Leukemia; 2003 Sep; 17(9):1916-7; author reply 1918. PubMed ID: 12970801
[No Abstract] [Full Text] [Related]
7. Current management and new approaches in the treatment of APL.
Tallman MS
Clin Adv Hematol Oncol; 2003 Oct; 1(10):580-1. PubMed ID: 16258453
[No Abstract] [Full Text] [Related]
8. Acute promyelocytic leukemia: what are the treatment options?
Ferrara F
Expert Opin Pharmacother; 2010 Mar; 11(4):587-96. PubMed ID: 20163270
[TBL] [Abstract][Full Text] [Related]
9. Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid.
Martini V; Minotti C; Breccia M; De Angelis G; Buffolino S; Mariella M; Lo-Coco F; Avvisati G; Cimino G
Ann Hematol; 2007 Apr; 86(4):295-7. PubMed ID: 17136541
[No Abstract] [Full Text] [Related]
10. Treatment of relapsed or refractory acute promyelocytic leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2007 Mar; 20(1):57-65. PubMed ID: 17336255
[TBL] [Abstract][Full Text] [Related]
11. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
[No Abstract] [Full Text] [Related]
12. [Management of relapsed acute promyelocytic leukemia].
Emi N
Nihon Rinsho; 2012 Apr; 70 Suppl 2():420-4. PubMed ID: 23133993
[No Abstract] [Full Text] [Related]
13. Simultaneous appearance of central nervous system relapse and subarachnoid hemorrhage during the treatment for acute promyelocytic leukemia.
Nagai S; Asai T; Watanabe T; Oshima K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Aoki S; Ohtomo K; Kurokawa M
Ann Hematol; 2008 Jul; 87(7):593-5. PubMed ID: 18204932
[No Abstract] [Full Text] [Related]
14. Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.
Fujita H; Asou N; Iwanaga M; Hyo R; Nomura S; Kiyoi H; Okada M; Inaguma Y; Matsuda M; Yamauchi T; Ohtake S; Izumi T; Nakaseko C; Ishigatsubo Y; Shinagawa K; Takeshita A; Miyazaki Y; Ohnishi K; Miyawaki S; Naoe T;
Cancer Sci; 2013 Oct; 104(10):1339-45. PubMed ID: 23837667
[TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
Alimoghaddam K; Ghavamzadeh A; Jahani M; Mousavi A; Iravani M; Rostami S; Ghaffari H; Hosseini R; Jalili M
Arch Iran Med; 2011 May; 14(3):167-9. PubMed ID: 21529103
[TBL] [Abstract][Full Text] [Related]
16. Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.
Tsimberidou AM; Estey E; Whitman GJ; Dryden MJ; Ratnam S; Pierce S; Faderl S; Giles F; Kantarjian HM; Garcia-Manero G
Leuk Res; 2004 Sep; 28(9):991-4. PubMed ID: 15234578
[TBL] [Abstract][Full Text] [Related]
17. Early relapse after non myeloablative allogeneic stem cell transplantation in a patient with acute promyelocytic leukemia in complete molecular remission.
Tavernier E; Thomas X
Indian J Cancer; 2003; 40(4):140-3. PubMed ID: 14716110
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
Takeshita A
Rinsho Ketsueki; 2003 Dec; 44(12):1133-43. PubMed ID: 14978929
[No Abstract] [Full Text] [Related]
19. Arsenicals and inhibitors of histone deacetylase as anticancer therapy.
Warrell RP
Haematologica; 1999 Jun; 84 Suppl EHA-4():75-7. PubMed ID: 10907475
[No Abstract] [Full Text] [Related]
20. Tamibarotene-induced low-grade reversible intravascular coagulation in a patient with acute promyelocytic leukemia.
Ohata K; Yamazaki H; Asakura H; Shimadoi S; Nakao S
Thromb Res; 2012 Feb; 129(2):213-4. PubMed ID: 21820159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
